83°

Topics

Johnson & Johnson Inc.
Johnson & Johnson to pay $2.2 billion for illegal drug marketing
Johnson & Johnson to pay $2.2 billion for illegal drug marketing

Johnson & Johnson will pay more than $2.2 billion in criminal and civil fines for marketing drugs Risperdal, Invega and Natrecor for uses they weren't approved for, the U.S. Justice Department announced Monday. The settlement, one the largest settlements of its kind, also covers charges that the company paid kickbacks to doctors and pharmacies promoting the drugs, the Justice Department said.  “The conduct at issue in this case jeopardized the health and safety of patients and damaged the public trust,” said Atty. Gen. Eric H. Holder Jr. in a statement.  In criminal filings Monday, the Justice Department said Janssen Pharmaceuticals, a subsidiary...

Loading